Supplemental material
Acta Oncologica
Volume 61, 2022 - Issue 8
Original Articles: Clinical Oncology
Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study
Anne Hansen Reea Department of Oncology, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]
https://orcid.org/0000-0002-8264-3223View further author information
https://orcid.org/0000-0002-8264-3223View further author information, , Kjersti Flatmarkc Department of Tumor Biology, Oslo University Hospital, Oslo, Norway;d Institute for Medical Biology, University of Tromsø – The Arctic University of Norway, Tromsø, Norway;e Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norwayhttps://orcid.org/0000-0001-7409-0780View further author information
https://orcid.org/0000-0001-7409-0780View further author information, , &